Zobrazeno 1 - 10
of 1 435
pro vyhledávání: '"Charter N"'
Autor:
Morwood, James
Publikováno v:
Pocket Oxford Latin Dictionary: English-Latin, 3 ed., 2012.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780191739576.001.0001/b-en-la-00001-0001958
Publikováno v:
Pocket Oxford Spanish Dictionary: English-Spanish, 4 ed., 2012.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780191735097.001.0001/b-en-es-00008-0002796
Autor:
Green, Jonathon
Publikováno v:
Green's Dictionary of Slang, 1 ed., 2011.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780199829941.001.0001/acref-9780199829941-e-6998
Autor:
Chalmers, Marianne, Pierquin, Martine
Publikováno v:
Oxford Business French Dictionary: English-French, 1 ed., 2003.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780191727283.001.0001/b-en-fr-00008-0001604
Autor:
López, Sinda, Watt, Donald
Publikováno v:
Oxford Business Spanish Dictionary: English-Spanish, 1 ed., 2003.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780191727290.001.0001/b-en-es-00009-0001559
Autor:
PENDER, KIERAN1
Publikováno v:
Melbourne University Law Review. 2023, Vol. 47 Issue 1, p192-228. 37p.
Autor:
Regier, Bradley J.1 (AUTHOR) bregier@ksu.edu
Publikováno v:
Journal of Research in Music Education. Oct2024, Vol. 72 Issue 3, p331-349. 19p.
Autor:
Nii T; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Prabhu VV; Oncoceutics, Inc., Philadelphia, PA, USA., Ruvolo V; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Madhukar N; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Zhao R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mu H; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heese L; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nishida Y; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kojima K; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, Saga, Japan., Garnett MJ; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge, UK., McDermott U; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Benes CH; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Charter N; DiscoverX Corporation, Fremont, CA, USA., Deacon S; DiscoverX Corporation, Fremont, CA, USA., Elemento O; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Allen JE; Oncoceutics, Inc., Philadelphia, PA, USA., Oster W; Oncoceutics, Inc., Philadelphia, PA, USA., Stogniew M; Oncoceutics, Inc., Philadelphia, PA, USA., Ishizawa J; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. JIshizawa@mdanderson.org., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mandreef@mdanderson.org.
Publikováno v:
Leukemia [Leukemia] 2019 Dec; Vol. 33 (12), pp. 2805-2816. Date of Electronic Publication: 2019 May 24.
Autor:
Prabhu VV; Oncoceutics, Philadelphia, Pennsylvania., Madhukar NS; Weill Cornell Medical College, New York, New York., Gilvary C; Weill Cornell Medical College, New York, New York., Kline CLB; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Oster S; Fox Chase Cancer Center, Philadelphia, Pennsylvania., El-Deiry WS; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Elemento O; Weill Cornell Medical College, New York, New York., Doherty F; HistoTox Labs, Inc., Boulder, Colorado., VanEngelenburg A; HistoTox Labs, Inc., Boulder, Colorado., Durrant J; HistoTox Labs, Inc., Boulder, Colorado., Tarapore RS; Oncoceutics, Philadelphia, Pennsylvania., Deacon S; Eurofins DiscoverX Corporation, Fremont, California., Charter N; Eurofins DiscoverX Corporation, Fremont, California., Jung J; Neuro-Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland., Park DM; The University of Chicago, Chicago, Illinois., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland., Rusert J; Sanford Burnham-Prebys Medical Discovery Institute, La Jolla, California., Wechsler-Reya R; Sanford Burnham-Prebys Medical Discovery Institute, La Jolla, California., Arrillaga-Romany I; Massachusettes General Hospital, Boston, Massachusetts., Batchelor TT; Massachusettes General Hospital, Boston, Massachusetts., Wen PY; Dana Farber Cancer Institute, Boston, Massachusetts., Oster W; Oncoceutics, Philadelphia, Pennsylvania., Allen JE; Oncoceutics, Philadelphia, Pennsylvania. josh.allen@oncoceutics.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Apr 01; Vol. 25 (7), pp. 2305-2313. Date of Electronic Publication: 2018 Dec 17.
Autor:
DEBELJAK, JULIE1
Publikováno v:
University of New South Wales Law Journal. 2022, Vol. 45 Issue 2, p570-616. 47p.